HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Maxillary sinus cancer review in 23 patients treated with postoperative radiotherapy].

AbstractOBJECTIVE:
To describe the survival and outcome of maxillary sinus cancer in patients managed with surgery and post-operative radiotherapy during the last 10 years in our hospital.
PATIENTS AND METHOD:
Descriptive, retrospective, non-randomized study of 23 patients with cancer of the maxillary sinus managed at the Vigo University Hospital Complex, Spain, with radical surgery and post-operative radiotherapy, between 1995 and 2004.
RESULTS:
The 3-year actuarial survival was 47.8% and the adjusted actuarial survival was 60.8%. Permanent local tumour control was achieved in 60.8% of cases (14/23). Local tumour recurrence was the main cause of treatment failure (33.3%; 4/12). The most significant prognostic factors affecting local tumour control and survival were: clinical stage (P< .031), suprastructural location of the tumour (P< .001), and presence of positive resection margins (P< .001).
CONCLUSIONS:
Local recurrence was found to be very high and generally the main cause of death. New treatment protocols should be assessed.
AuthorsRubén D Manrique, Leopoldo G Deive, Michel A Uehara, Roslyn K Manrique, José L Rodríguez, Carmelo Santidrian
JournalActa otorrinolaringologica espanola (Acta Otorrinolaringol Esp) Vol. 59 Issue 1 Pg. 6-10 (Jan 2008) ISSN: 0001-6519 [Print] Spain
Vernacular TitleRevisión del cáncer de seno maxilar en 23 pacientes tratados con radioterapia postoperatoria.
PMID18215383 (Publication Type: English Abstract, Journal Article)
Topics
  • Aged
  • Aged, 80 and over
  • Combined Modality Therapy
  • Female
  • Humans
  • Male
  • Maxillary Sinus Neoplasms (radiotherapy, surgery)
  • Middle Aged
  • Neoplasm Staging
  • Postoperative Care
  • Retrospective Studies

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: